Global Coagulation Testing Market by Product (Consumables, Instruments), Test Type (Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time), End-User

The Coagulation Testing Market grew from USD 4.62 billion in 2023 to USD 5.07 billion in 2024. It is expected to continue growing at a CAGR of 9.92%, reaching USD 8.96 billion by 2030.

These tests are critical in diagnosing and managing various conditions that affect the blood's clotting capability, such as hemophilia, thrombosis, and liver disease. They are also essential in monitoring patients on anticoagulation therapy to ensure safe and effective treatment outcomes. The rising prevalence of cardiovascular diseases and blood disorders has increased the adoption of coagulation testing. Additionally, the aging global population at higher risk of blood-related disorders also significantly raises the need for coagulation testing. However, the high cost of coagulation testing devices and stringent regulatory requirements for the new devices' approval delay product launches, affecting market dynamics. Despite these challenges, increasing investment in healthcare infrastructure in emerging economies provides a future growth prospect. Furthermore, ongoing research and development activities aiming to introduce innovative and efficient coagulation testing solutions are expected to offer new avenues for expansion.

Regional Insights

In the Americas, coagulation testing is getting highly adopted owing to the high prevalence of cardiovascular diseases and an increasing aging population, particularly in North America. The United States showcases higher adoption, supported by advanced healthcare infrastructure and favorable reimbursement policies. The EMEA region presents diverse scenarios in the coagulation testing market, with Europe having a high adoption rate. The growth in Europe is spurred by the increasing adoption of point-of-care (POC) testing devices for faster and more efficient diagnosis, alongside strong healthcare systems and a higher level of patient awareness. The Middle East and Africa are witnessing gradual growth, with initiatives by governments and NGOs to improve healthcare facilities. Asia-Pacific is projected to be the biggest market for coagulation testing, driven by rapidly developing healthcare infrastructure and a large patient pool. Countries inclduing China and India are at the forefront of the adoption of coagulation testing, with their growing middle-class populations and increased focus on healthcare reform. Furthermore, the expanding research and development activities in the region to develop affordable testing solutions are expected to boost the market in this region.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Coagulation Testing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

Increasing prevalence of coagulation disorders worldwide
Government campaigns promoting awareness of life-threatening blood clots

Market Restraints

Lack of reimbursements for coagulation testing

Market Opportunities

Advancements in coagulation testing technologies
Emergence of coagulation testing for homecare

Market Challenges

Technical limitations and inaccuracies of coagulation testing

Market Segmentation Analysis

Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing
End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring

Industry Insights

Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Coagulation Testing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Coagulation Testing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need

Roche has introduced three new coagulation tests for the oral Factor Xa inhibitors apixaban, edoxaban, and rivaroxaban, available in countries recognizing the CE mark. Roche aims to enhance lab efficiency with their tests' compatibility with cobas t analysers and innovative Anti-Xa cassette technology, which standardizes the testing process and minimizes user intervention, contamination, and evaporation risks, thus facilitating a streamlined and more effective use of reagents and potentially improving patient outcomes.

HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023

HORIBA has announced the expansion of its coagulation testing capabilities in the UK with the introduction of its cutting-edge, fully automated haemostasis analysers, the high-throughput Yumizen G1500h/G1550h and the compact Yumizen G800h/G850h models. These advanced systems are engineered to elevate precision by efficiently pinpointing and analyzing HIL interferences (haemolysis, icterus, and lipemia) in each coagulation test, alongside automatically assessing the primary tubes for adequacy of fill levels.

Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers

Diagnostica Stago has achieved a significant milestone with the US Food and Drug Administration's 510(k) clearance for its latest Max Generation analyzers, the STA R Max3 and STA Compact Max3, designed to improve the diagnosis and monitoring of coagulation disorders and anticoagulant therapy. Engineered with cutting-edge features, these fully automated analyzers provide comprehensive testing capabilities such as clot-based, immunoturbidimetric, and colorimetric assessments.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Coagulation Testing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Testing Market, highlighting leading vendors and their innovative profiles. These include A&T Corporation, Abbott Laboratories, Advin Health Care, Becton, Dickinson and Company, Beijing Succeeder Technology Inc., Bio Group Medical System SRL, Bio-Rad Laboratories, Inc., Coagulation Sciences LLC, Danaher Corporation, Drucker Diagnostics, LLC, F. Hoffmann-La Roche Ltd, Genrui Biotech Inc., Helena Laboratories Corporation, HORIBA, Ltd., Maccura Biotechnology Co., Ltd., Medtronic PLC, Mindray Bio-Medical Electronics Co., Ltd., Sekisui Chemical Co., Ltd., Shenzhen Micropoint Biotechnologies Co., Ltd., Siemens Healthineers AG, Stago Group, Sysmex Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Tulip Diagnostics (P) Ltd.

Market Segmentation & Coverage

This research report categorizes the Coagulation Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product

Consumables
Instruments

Test Type

Activated Partial Thromboplastin Time
Prothrombin Time
Thrombin Time

End-User

Clinical Laboratories
Home Testing
Hospitals

Region

Americas

Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific

Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa

Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of coagulation disorders worldwide
5.1.1.2. Government campaigns promoting awareness of life-threatening blood clots
5.1.2. Restraints
5.1.2.1. Lack of reimbursements for coagulation testing
5.1.3. Opportunities
5.1.3.1. Advancements in coagulation testing technologies
5.1.3.2. Emergence of coagulation testing for homecare
5.1.4. Challenges
5.1.4.1. Technical limitations and inaccuracies of coagulation testing
5.2. Market Segmentation Analysis
5.2.1. Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing
5.2.2. End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Coagulation Testing Market, by Product

6.1. Introduction
6.2. Consumables
6.3. Instruments

7. Coagulation Testing Market, by Test Type

7.1. Introduction
7.2. Activated Partial Thromboplastin Time
7.3. Prothrombin Time
7.4. Thrombin Time

8. Coagulation Testing Market, by End-User

8.1. Introduction
8.2. Clinical Laboratories
8.3. Home Testing
8.4. Hospitals

9. Americas Coagulation Testing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Coagulation Testing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Coagulation Testing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need
12.3.2. HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023
12.3.3. Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio

List of Figures

FIGURE 1. COAGULATION TESTING MARKET RESEARCH PROCESS
FIGURE 2. COAGULATION TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. COAGULATION TESTING MARKET DYNAMICS
FIGURE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. COAGULATION TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL COAGULATION TESTING MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 49. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 50. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 51. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 52. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 53. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 56. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 57. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 58. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 59. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 84. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 85. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 86. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 87. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 90. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 91. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 92. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 93. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 102. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 103. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 104. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 105. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 138. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 139. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 140. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 141. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 158. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 159. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 160. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 161. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 164. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 165. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 166. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 167. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 170. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 171. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 172. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 173. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 176. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 177. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 178. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 179. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 182. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 183. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 184. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 185. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 194. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 195. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 196. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 197. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 212. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 213. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 214. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 215. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 218. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 219. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 220. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 221. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 224. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 225. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 226. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 227. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 248. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 249. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 250. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 251. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 266. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 267. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 268. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 269. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

A&T Corporation
Abbott Laboratories
Advin Health Care
Becton, Dickinson and Company
Beijing Succeeder Technology Inc.
Bio Group Medical System SRL
Bio-Rad Laboratories, Inc.
Coagulation Sciences LLC
Danaher Corporation
Drucker Diagnostics, LLC
F. Hoffmann-La Roche Ltd
Genrui Biotech Inc.
Helena Laboratories Corporation
HORIBA, Ltd.
Maccura Biotechnology Co., Ltd.
Medtronic PLC
Mindray Bio-Medical Electronics Co., Ltd.
Sekisui Chemical Co., Ltd.
Shenzhen Micropoint Biotechnologies Co., Ltd.
Siemens Healthineers AG
Stago Group
Sysmex Corporation
Thermo Fisher Scientific Inc.
Trivitron Healthcare
Tulip Diagnostics (P) Ltd

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	197
Published	June 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.07 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.96 Billion
Compound Annual Growth Rate	9.9%
Regions Covered	Global

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3694EUR$3,939USD£3,077GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4641EUR$4,949USD£3,866GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6536EUR$6,969USD£5,444GBP

Global Coagulation Testing Market by Product (Consumables, Instruments), Test Type (Activated Partial Thromboplastin Time, Prothrombin Time, Thrombin Time), End-User - Forecast 2024-2030

Regional Insights

Market Insights

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Market Segmentation Analysis

Industry Insights

FPNV Positioning Matrix

Market Share Analysis

Recent Developments

Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need

HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023

Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers

Strategy Analysis & Recommendation

Key Company Profiles

Market Segmentation & Coverage

Product

Test Type

End-User

Region

Americas

Asia-Pacific

Europe, Middle East & Africa

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Regional Insights

Market Insights

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Market Challenges

Market Segmentation Analysis

Industry Insights

FPNV Positioning Matrix

Market Share Analysis

Recent Developments

Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need

HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023

Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers

Strategy Analysis & Recommendation

Key Company Profiles

Market Segmentation & Coverage

Product

Test Type

End-User

Region

Americas

Asia-Pacific

Europe, Middle East & Africa

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Related Topics

Related Reports

Global Coagulation & Hemostasis Testing Market by Test Type (Activated Partial Thromboplastin Time, D-Dimer Testing, Fibrinogen Testing), Technology (Electrochemical Technology, Mechanical Technology, Optical Technology), End-Use - Forecast 2024-2030

Global Coagulation Testing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

Coagulation Analyzer Market Report by Testing Type, Product Type, Technology Type, End User, and Region 2024-2032

Coagulation Testing - Global Strategic Business Report

Coagulation Analyzer Global Market Report 2024

About the Blood Coagulation Test Market